Skip to main content

. 2006 May 3;8(3):406. doi: 10.1186/bcr1413

Correction: Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

Trevor Powles ^1,^✉, Alexander Paterson ², Eugene McCloskey ³, Phil Schein ⁴, Bobbi Scheffler ⁵, Alwynne Tidy ⁶, Sue Ashley ⁶, Ian Smith ⁶, Lars Ottestad ⁷, John Kanis ³

PMCID: PMC1557728

It has been brought to our attention that there was a typographical error in our recent article [1] published in March 2006.

In the Conclusions section the final sentence should read:

Questions such as the optimal duration of therapy and efficacy in stage I disease remain to be answered.

References

Powles T, Paterson A, McCloskey E, Schein P, Scheffler B, Tidy A, Ashley S, Smith I, Ottestad L, Kanis J. Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026] Breast Cancer Research. 2006;8:R13. doi: 10.1186/bcr1384. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES